Clinical laboratory tests play a crucial role in making sure patients get appropriate care, yet many small labs and clinics in low resource settings cannot afford the instruments needed to provide these tests. Research on a novel fingerprick test that can perform all common clinical diagnostics could help to expand access to basic medical testing in the developing world, and will be featured at the 2015 AACC Annual Meeting & Clinical Lab Expo.
Public health experts estimate that approximately one third of the world’s population does not have adequate access to quality healthcare due to a range of barriers, from limited geographic accessibility to a lack of affordable services. Clinical laboratories in particular are poorly outfitted and sparsely distributed in low-income countries, and few primary healthcare centers in these regions are located within reach of a well-equipped and staffed lab. So-called point-of-care testing devices that are portable and do not require lab support could improve access to testing in underserved areas. However, multiple point-of-care instruments would be required to run the full spectrum of common clinical tests, and this equipment is often expensive.
At AACC’s 2015 Annual Meeting, researchers from DiaSys Diagnostics India in Mumbai will present the first point-of-care device, named QDx InstaLab, that can perform all of the clinical tests that labs routinely order as part of yearly physicals to evaluate organ function and check for conditions such as diabetes, liver disease, and kidney disease. Additionally, the QDx InstaLab can test cholesterol levels to screen for risk of heart disease or to monitor treatment for it, and can screen for bleeding problems or monitor treatment for inappropriate blood clotting as well. To run these numerous tests, the device analyzes a few drops of blood from a fingerprick using inexpensive microfluidic cartridge technology together with novel nanomaterial-based plastic electrochemical biosensors. It provides results in 3 to 10 minutes or less.
To evaluate QDx InstaLab’s accuracy, the researchers performed each of its tests on 40 to 70 patient blood samples and compared the results with those of standard laboratory instruments. Through this, they found that the tests run on QDx InstaLab have a coefficient of variation < 3%, an R² value > 0.95, and an interference bias < 10%, which signifies that the QDX InstaLab is reliable and meets all the performance specifications of a lab.
The Latest on: Point-of-care testing devices
via Google News
The Latest on: Point-of-care testing devices
- Blood Testing Market Forecast & Opportunities 2019: Abbott Laboratories, Ortho Clinical Diagnostics, F. Hoffmann La Roche on March 23, 2019 at 10:06 pm
Additionally, integration of software application with blood testing devices will enhance the growth opportunities ... on early diagnosis of disease and growing awareness about point-of-care testing ... […]
- HbA1c point-of-care test reliably diagnoses diabetes on March 21, 2019 at 4:14 am
“However, the variable performance of some previous [point-of-care] devices in combination with a lack of mandatory proficiency testing in some [point-of-care] settings has led the [American Diabetes ... […]
- Theranos screwed up legit blood test innovations for everybody on March 20, 2019 at 11:25 am
But will the dream of a device that can analyze multiple health ... the underlying idea of portable, low-impact, point-of-care testing. Using a small amount of blood to run diagnostics for one ... […]
- Mesa Biotech Named 2019 Frost & Sullivan Price/Performance Value Leader in Global Influenza Point-of-Care Testing on March 20, 2019 at 5:00 am
The Frost & Sullivan Best Practices Award compared Mesa Biotech's Accula™ System against competitor devices on key criteria such ... Value Leadership Award in the influenza point-of-care testing ... […]
- Paper Diagnostics Market Analysis Report By Device Type, By Application, By Product, By End Use And Segment Forecasts, 2018 - 2025 on March 19, 2019 at 5:24 pm
For instance, in March 2017, ARKRAY Inc. launched saliva testing system ... efficiency • Paper based diagnostic devices are widely used as point-of-care diagnostics. Increasing inclination ... […]
- Science Researchers Uses Laser Method To Develop HIV Viral Load Portable Device on March 19, 2019 at 9:34 am
Although viral load testing cannot alleviate the HIV epidemic, the accessibility of the device, particularly in low-resourced ... lab-on-a-chip approach to develop cost-effective point-of-care ... […]
- Fertility Testing Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2023 on March 15, 2019 at 4:41 pm
Additionally, the adoption of the point of care devices and the increasing prevalence of ovarian diseases are the key attributing factor for fueling the growth of fertility testing devices market. Try ... […]
- Sweat holds most promise for noninvasive testing on March 15, 2019 at 1:07 pm
Instead of shipping samples to a lab, doctors could test samples themselves using tiny self-contained devices. "Dr. Ahn has been at the forefront of developing these point-of-care devices," Heikenfeld ... […]
- Global Fertility Testing Devices Research and Forecast, 2018-2023 on March 12, 2019 at 2:08 am
Additionally, the adoption of the point of care devices and the increasing prevalence of ovarian diseases are the key attributing factor for fueling the growth of fertility testing devices market. A ... […]
- India- Global Point of Care Diagnostic Devices Market 2019 Analysis, Growth, Share, Trends, Segmentation Forecast To 2025 on March 11, 2019 at 8:12 am
Point of Care Diagnostic Devices Market 2019 Wiseguyreports.Com ... Description: Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. […]
via Bing News